{"nct_id":"NCT05357950","title":"A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2022-05-31","start_date_type":"ACTUAL","primary_completion_date":"2023-11-02","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NRSN"]}